SNTI logo

Senti Biosciences (SNTI) Company Overview

Profile

Full Name:

Senti Biosciences, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 26, 2021

Indexes:

Not included

Description:

Senti Biosciences (SNTI) is a biotechnology company focused on developing advanced gene therapies. They use innovative technologies to create treatments for various diseases, aiming to improve patient outcomes. Their work combines synthetic biology and gene editing to design precise and effective therapies.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 18, 2024

Analyst ratings

Recent major analysts updates

Dec 4, 24 Chardan Capital
Buy
Dec 2, 24 Chardan Capital
Buy
Aug 15, 23 Chardan Capital
Buy
May 11, 23 Chardan Capital
Buy
Mar 24, 23 Morgan Stanley
Equal-Weight
Mar 23, 23 Chardan Capital
Buy
Jan 30, 23 Chardan Capital
Buy
Jan 27, 23 Morgan Stanley
Equal-Weight
Dec 16, 22 JP Morgan
Neutral
Oct 7, 22 Morgan Stanley
Equal-Weight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Senti Biosciences Inc.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Senti Biosciences Inc.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Senti Biosciences Inc.
SNTI
accessnewswire.comFebruary 7, 2025

NEW YORK, NY / ACCESS Newswire / February 7, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Senti Biosciences Inc ("SNTI" or the "Company") (NASDAQ:SNTI) Stock purchased prior to June 1, 2022. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Dynamics Special Purpose Co., and whether the Board of SNTI harmed stockholders, and whether all material facts had been properly disclosed to stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into Senti Biosciences Inc
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into Senti Biosciences Inc
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into Senti Biosciences Inc
SNTI
accessnewswire.comFebruary 6, 2025

NEW YORK, NY / ACCESS Newswire / February 6, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Senti Biosciences Inc ("SNTI" or the "Company") (NASDAQ:SNTI) Stock purchased prior to June 1, 2022. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Dynamics Special Purpose Co., and whether the Board of SNTI harmed stockholders, and whether all material facts had been properly disclosed to stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc.
SNTI
accessnewswire.comFebruary 5, 2025

NEW YORK, NY / ACCESS Newswire / February 5, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Senti Biosciences Inc ("SNTI" or the "Company") (NASDAQ:SNTI) Stock purchased prior to June 1, 2022. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Dynamics Special Purpose Co., and whether the Board of SNTI harmed stockholders, and whether all material facts had been properly disclosed to stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Senti Biosciences Inc.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Senti Biosciences Inc.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Senti Biosciences Inc.
SNTI
accessnewswire.comFebruary 4, 2025

NEW YORK, NY / ACCESS Newswire / February 4, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Senti Biosciences Inc ("SNTI" or the "Company") (NASDAQ:SNTI) Stock purchased prior to June 1, 2022. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Dynamics Special Purpose Co., and whether the Board of SNTI harmed stockholders, and whether all material facts had been properly disclosed to stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc
SNTI
accessnewswire.comFebruary 3, 2025

NEW YORK, NY / ACCESS Newswire / February 3, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Senti Biosciences Inc ("SNTI" or the "Company") (NASDAQ:SNTI) Stock purchased prior to June 1, 2022. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Dynamics Special Purpose Co., and whether the Board of SNTI harmed stockholders, and whether all material facts had been properly disclosed to stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into Senti Biosciences Inc
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into Senti Biosciences Inc
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into Senti Biosciences Inc
SNTI
accessnewswire.comJanuary 31, 2025

NEW YORK, NY / ACCESS Newswire / January 31, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Senti Biosciences Inc ("SNTI" or the "Company") (NASDAQ:SNTI) Stock purchased prior to June 1, 2022. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Dynamics Special Purpose Co., and whether the Board of SNTI harmed stockholders, and whether all material facts had been properly disclosed to stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Senti Biosciences Inc.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Senti Biosciences Inc.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Senti Biosciences Inc.
SNTI
accessnewswire.comJanuary 30, 2025

NEW YORK, NY / ACCESS Newswire / January 30, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Senti Biosciences Inc ("SNTI" or the "Company") (NASDAQ:SNTI) Stock purchased prior to June 1, 2022. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Dynamics Special Purpose Co., and whether the Board of SNTI harmed stockholders, and whether all material facts had been properly disclosed to stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into Senti Biosciences Inc
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into Senti Biosciences Inc
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into Senti Biosciences Inc
SNTI
accessnewswire.comJanuary 29, 2025

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Senti Biosciences Inc ("SNTI" or the "Company") (NASDAQ:SNTI) Stock purchased prior to June 1, 2022. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Dynamics Special Purpose Co., and whether the Board of SNTI harmed stockholders, and whether all material facts had been properly disclosed to stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc
SNTI
accessnewswire.comJanuary 28, 2025

NEW YORK, NY / ACCESS Newswire / January 28, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Senti Biosciences Inc ("SNTI" or the "Company") (NASDAQ:SNTI) Stock purchased prior to June 1, 2022. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Dynamics Special Purpose Co., and whether the Board of SNTI harmed stockholders, and whether all material facts had been properly disclosed to stockholders.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc.
SNTI
accessnewswire.comJanuary 27, 2025

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Senti Biosciences Inc ("SNTI" or the "Company") (NASDAQ:SNTI) Stock purchased prior to June 1, 2022. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Dynamics Special Purpose Co., and whether the Board of SNTI harmed stockholders, and whether all material facts had been properly disclosed to stockholders.

FAQ

  • What is the ticker symbol for Senti Biosciences?
  • Does Senti Biosciences pay dividends?
  • What sector is Senti Biosciences in?
  • What industry is Senti Biosciences in?
  • What country is Senti Biosciences based in?
  • When did Senti Biosciences go public?
  • Is Senti Biosciences in the S&P 500?
  • Is Senti Biosciences in the NASDAQ 100?
  • Is Senti Biosciences in the Dow Jones?
  • When was Senti Biosciences's last earnings report?
  • When does Senti Biosciences report earnings?
  • Should I buy Senti Biosciences stock now?

What is the ticker symbol for Senti Biosciences?

The ticker symbol for Senti Biosciences is NASDAQ:SNTI

Does Senti Biosciences pay dividends?

No, Senti Biosciences does not pay dividends

What sector is Senti Biosciences in?

Senti Biosciences is in the Healthcare sector

What industry is Senti Biosciences in?

Senti Biosciences is in the Biotechnology industry

What country is Senti Biosciences based in?

Senti Biosciences is headquartered in United States

When did Senti Biosciences go public?

Senti Biosciences's initial public offering (IPO) was on May 26, 2021

Is Senti Biosciences in the S&P 500?

No, Senti Biosciences is not included in the S&P 500 index

Is Senti Biosciences in the NASDAQ 100?

No, Senti Biosciences is not included in the NASDAQ 100 index

Is Senti Biosciences in the Dow Jones?

No, Senti Biosciences is not included in the Dow Jones index

When was Senti Biosciences's last earnings report?

Senti Biosciences's most recent earnings report was on Nov 14, 2024

When does Senti Biosciences report earnings?

The next expected earnings date for Senti Biosciences is Mar 21, 2025

Should I buy Senti Biosciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions